{"data":{"id":"us-nv/nrs-639.2597","jurisdiction":"us-nv","citation":"NRS 639.2597","heading":"Use of list of biologically equivalent drugs or interchangeable biological products.","body":"A pharmacist or practitioner who proposes to make any substitution must have made use of a list of biologically equivalent drugs or interchangeable biological products approved by the United States Food and Drug Administration.","path":["TITLE 54 — PROFESSIONS, OCCUPATIONS AND BUSINESSES","CHAPTER 639 - PHARMACISTS AND PHARMACY","REGULATION OF TRADE PRACTICES","Collaborative Practice of Pharmacy; Collaborative Drug Therapy Management"],"source_url":"https://www.leg.state.nv.us/NRS/NRS-639.html#NRS639Sec2597","current_through":"2025 session (NRS as revised 2026-08-25)","vintage":"","retrieved_at":"2026-09-03T05:51:44Z","sha256":"c6def61e703252f130e84995d0394ff0d62e36af1fd3dd2456d967d527384a5e","source_id":"us-nv","stale":true,"prev":"us-nv/nrs-639.2596","next":"us-nv/nrs-639.2623"},"notice":"GroundRules: Original legal text. Not legal advice."}